- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Teva’s HCP and education websites were ruled promotional in parts. Breaches included missing prominent PI/AE signposting online, missing PI for some products,…
A senior BMS UK employee ‘liked’ a US colleague’s LinkedIn post that linked (via Twitter) to a US press release naming Opdivo…
Lilly alleged Novo Nordisk’s GLP-1RA CVOT slide deck misled HCPs by inviting comparisons and omitting primary vs secondary prevention context. Panel and…
Two AstraZeneca press releases described its COVID-19 vaccine as “safe” and presented efficacy as relative risk reduction without absolute risk context. PMCPA…
AbbVie challenged Jyseleca RA website claims. Panel found “consistently low rates” safety claim misleading/unsupported and ‘At a glance’ efficacy summary misleading/incomplete. No…
Bayer challenged Janssen’s Erleada promotional video alleging off-licence promotion and misleading/disparaging cross-trial safety comparisons. The PMCPA Panel ruled no breach of Clauses…
Novo Nordisk and a pharmacist association co-developed a weight management hub. PMCPA found Novo’s exact involvement wasn’t clearly declared at the outset…
Leo admitted two Kyntheum promotional webpages went live in forms that were not UK-certified (one differed from certified content; one was a…
Novartis’ Mayzent dosing webpage referenced initiation/ECG monitoring for patients with MI/heart failure history but didn’t make clear the absolute 6‑month contraindication. Breaches…
UCB’s Bimzelx leavepiece used in vitro pathway claims and cytokine level data in a way that implied clinical superiority vs IL‑17A inhibitors.…
Complaint alleged LinkedIn promotion and breach of an undertaking by AstraZeneca. PMCPA concluded the matter was outwith the scope of the ABPI…
Grünenthal voluntarily admitted it could not locate/retain ~30 certified hard-copy items and signatures. The PMCPA ruled breaches of Clauses 5.1 and 8.6…
Two downloadable documents on Novartis’ HCP portal contained outdated Entresto prescribing information (May 2021 and June 2020) while the webpage PI was…
Complaint alleged Otsuka’s Abilify Maintena tracking market research was promotional and used patient record forms like a clinical study, plus weak approvals.…
A paediatrician at an NHS trial site circulated a WhatsApp recruitment message for Moderna’s NextCOVE trial offering £1,500 on completion. PMCPA found…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.